STAB Company Profile and Key Details

Q: Who are the executives of STAB?

Mr. Michael Kevin HandleyChief Executive Officer, Pres & ChairmanGeorge WagnerExecutive Vice President of Regulatory AffairsDr. Robert W. Buckheit Jr., Ph.D.Chief Technology OfficerTodd HeadleyExecutive Vice President of Corporation Devel.Mr. Christopher ZoshExecutive Vice President of Fin., Interim Principal Financial Officer & Interim Principal Accounting Officer

NASDAQ : STAB

Statera Biopharma

$0.00

At Close 4:00 PM

63.85

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Statera Biopharma, Inc. (STAB) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.

Stock Snapshot

0.0002

Prev. Close

14.28K

Market Cap

0.0001

Day Low

N/A

P/E Ratio

-1.01

EPS (TTM)

-0.81

Cash Flow per Share

Open

71.42M

Number of Shares

0.0002

Day High

67.36%

Free Float in %

-0.04

Book Value

700

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 09, 2026	0.00	0.00	0.00	0.00	3.29K
Sep 08, 2026	0.00	0.00	0.00	0.00	523
Sep 04, 2026	0.00	0.00	0.00	0.00	595
Sep 01, 2026	0.00	0.00	0.00	0.00	611.49K
Aug 31, 2026	0.00	0.00	0.00	0.00	495
Aug 28, 2026	0.00	0.00	0.00	0.00	2K
Aug 27, 2026	0.00	0.00	0.00	0.00	111
Aug 25, 2026	0.00	0.00	0.00	0.00	789
Aug 24, 2026	0.00	0.00	0.00	0.00	189
Aug 21, 2026	0.00	0.00	0.00	0.00	4.63K
Aug 17, 2026	0.00	0.00	0.00	0.00	2.13K
Aug 12, 2026	0.00	0.00	0.00	0.00	2K
Aug 11, 2026	0.00	0.00	0.00	0.00	5K
Aug 10, 2026	0.00	0.00	0.00	0.00	1K
Aug 07, 2026	0.00	0.00	0.00	0.00	16.57K
Aug 06, 2026	0.00	0.00	0.00	0.00	20.1K
Aug 05, 2026	0.00	0.00	0.00	0.00	3.93K
Aug 04, 2026	0.00	0.00	0.00	0.00	10.12K
Jul 30, 2026	0.00	0.00	0.00	0.00	902
Jul 29, 2026	0.00	0.00	0.00	0.00	1.5K

Contact Details

Fort Collins, CO 80525

United States

https://www.staterabiopharma.com 888 613 8802

About Company

Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies. These novel treatments aim to address a range of serious conditions, including autoimmune disorders, neutropenia, anemia, emerging viral infections, and various cancers. This development is underpinned by a proprietary technological platform engineered to restore the body's immune system balance and re-establish overall physiological homeostasis. The company's therapeutic strategies are designed to directly stimulate patients' immune systems, specifically eliciting antigen-specific killer T-cells and antibodies to activate crucial defenses against inflammatory, infectious, and cancerous diseases. Statera BioPharma's clinical pipeline features programs such as STAT-201 for Crohn's disease, Entolimod for hematological conditions, STAT-401 for pancreatic cancer, and STAT-205 for COVID-19. The company is also actively exploring therapeutic applications for fibromyalgia and multiple sclerosis. Formerly known as Cytocom, Inc., the company officially adopted the name Statera BioPharma, Inc. in September 2021. Its operations are headquartered in Fort Collins, Colorado.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current Statera Biopharma, Inc. (STAB) stock price?

Statera Biopharma, Inc. (OTC: STAB) stock price is $0.00 in the last trading session. During the trading session, STAB stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in STAB stock occurred in the recent session was 0% while the dollar amount for the price change in STAB stock was $0.00.

STAB's industry and sector of operation?

The OTC listed STAB is part of Biotechnology industry that operates in the broader Healthcare sector. Statera Biopharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of STAB?

Mr. Michael Kevin Handley
Chief Executive Officer, Pres & Chairman
George Wagner
Executive Vice President of Regulatory Affairs
Dr. Robert W. Buckheit Jr., Ph.D.
Chief Technology Officer
Todd Headley
Executive Vice President of Corporation Devel.
Mr. Christopher Zosh
Executive Vice President of Fin., Interim Principal Financial Officer & Interim Principal Accounting Officer

How STAB did perform over past 52-week?

STAB's closing price is 100% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.03 is -99.25%.

How many employees does STAB have?

Number of STAB employees currently stands at 46.

Link for STAB official website?

Official Website of STAB is: https://www.staterabiopharma.com

How do I contact STAB?

STAB could be contacted at phone 888 613 8802 and can also be accessed through its website. STAB operates from 4333 Corbett Drive,, Fort Collins, CO 80525, United States.

How many shares of STAB are traded daily?

STAB stock volume for the day was 700 shares. The average number of STAB shares traded daily for last 3 months was 12.93K.

What is the market cap of STAB currently?

The market value of STAB currently stands at $14.28K with its latest stock price at $0.00 and 71.42M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	46
Beta	-4.78
Sales or Revenue	$0.00
5Y Sales Change%	N/A
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	46
Beta	-4.78
Sales or Revenue	$0.00
5Y Sales Change%	N/A
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

STAB Company Profile and Key Details

Statera Biopharma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Dividend & Fair Value

Valuation Metrics

Price Forecast & Outlook

Key Takeaways